Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H2472 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 1 of 1
22 HOUSE DOCKET, NO. 1476 FILED ON: 1/15/2025
33 HOUSE . . . . . . . . . . . . . . . No. 2472
44 The Commonwealth of Massachusetts
55 _________________
66 PRESENTED BY:
77 Kathleen R. LaNatra
88 _________________
99 To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
1010 Court assembled:
1111 The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
1212 An Act protecting patient safety regarding non-FDA approved drugs.
1313 _______________
1414 PETITION OF:
1515 NAME:DISTRICT/ADDRESS :DATE ADDED:Kathleen R. LaNatra12th Plymouth1/15/2025Patrick Joseph Kearney4th Plymouth2/3/2025 1 of 4
1616 HOUSE DOCKET, NO. 1476 FILED ON: 1/15/2025
1717 HOUSE . . . . . . . . . . . . . . . No. 2472
1818 By Representative LaNatra of Kingston, a petition (accompanied by bill, House, No. 2472) of
1919 Kathleen R. LaNatra and Patrick Joseph Kearney relative to the distribution of compounded
2020 medications. Public Health.
2121 The Commonwealth of Massachusetts
2222 _______________
2323 In the One Hundred and Ninety-Fourth General Court
2424 (2025-2026)
2525 _______________
2626 An Act protecting patient safety regarding non-FDA approved drugs.
2727 Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
2828 of the same, as follows:
2929 1 Section 1. As used in this section, the following words shall have the following
3030 2meanings:
3131 3 a) "Compounded Medication" means a medication that is prepared, mixed, assembled,
3232 4altered, or otherwise modified by a licensed pharmacist to meet the unique needs of an individual
3333 5patient pursuant to a prescription.
3434 6 b) "Retail Pharmacy" means any establishment, including a community pharmacy,
3535 7licensed by the state to dispense prescription medications directly to patients.
3636 8 c) "Resale" means selling, distributing, or otherwise transferring a medication that a retail
3737 9pharmacy has purchased, in any quantity, to another entity or individual who is not the patient
3838 10for whom the medication was originally compounded.
3939 11 Section 2. 2 of 4
4040 12 In order to ensure the safe and ethical distribution of compounded medications:
4141 13 (a) No retail pharmacy shall resell compounded medications.
4242 14 (b) Compounded medications prepared by a retail pharmacy shall be dispensed only to
4343 15the patient for whom the medication was originally compounded, pursuant to a valid
4444 16prescription.
4545 17 (c) Any violation of this section shall subject the retail pharmacy to disciplinary actions
4646 18as determined by the state's Board of Registration in Pharmacy, including but not limited to
4747 19fines, suspension, or revocation of the pharmacy's license.
4848 20 Section 3.
4949 21 (1) The resale of a compounded drug that is labeled “not for resale” in accordance with
5050 22section (2)(c)(ix) is prohibited.
5151 23 (2) The label of any drug compounded or repackaged by an outsourcing facility shall
5252 24include, but not be limited to the following:
5353 25 (a) a statement that the compounded drug is a compounded drug or a reasonable
5454 26comparable alternative statement that prominently identifies the drug as a compounded drug;
5555 27 (b) the name, address, and phone number of the applicable outsourcing facility; and
5656 28 (c) with respect to the compounded drug:
5757 29 (i) the lot or batch number;
5858 30 (ii) the established name of the drug; 3 of 4
5959 31 (iii) the dosage form and strength;
6060 32 (iv) the statement of quantity or volume, as appropriate;
6161 33 (v) the date that the drug was compounded;
6262 34 (vi) the expiration date;
6363 35 (vii) storage and handling instructions;
6464 36 (viii) the NDC number, if available;
6565 37 (ix) the statement that the drug is not for resale, and if the drug product is distributed by
6666 38an outsourcing facility other than pursuant to a prescription for an individual identified patient,
6767 39the statement “office use only”;
6868 40 (x) a list of the active and inactive ingredients, identified by established name, and the
6969 41quantity or proportion of each ingredient.
7070 42 (3) The container from which the individual units of the compounded drug are removed
7171 43for dispensing or for administration (such as a plastic bag containing individual product syringes)
7272 44shall include-- (a) a list of active and inactive ingredients, identified by established name, and the
7373 45quantity or proportion of each ingredient; (b) the following information to facilitate adverse
7474 46event reporting: www.fda.gov/medwatch and 1-800-FDA-1088 (or any successor Internet Web
7575 47site or phone number); and (c) directions for use, including, as appropriate, dosage and
7676 48administration.
7777 49 (4) No compounded or repackaged drug will be sold or transferred by any entity other
7878 50than the outsourcing facility that compounded or repackaged such drug. This does not prohibit 4 of 4
7979 51the administration of a drug in a health care setting or an outsourcing facility dispensing a drug
8080 52pursuant to a properly executed prescription.
8181 53 (5) A compounded drug labeled “office use only” in accordance with section (2)(c)(ix)
8282 54shall be administered in the office and not dispensed to the patient.
8383 55 Section 4. Enforcement
8484 56 (a) The state's Board of Registration in Pharmacyshall have the power to enforce the
8585 57provisions of this Act.
8686 58 (b) The regulatory authority is authorized to promulgate rules and regulations necessary
8787 59for the implementation and enforcement of this Act.
8888 60 Section 5. Severability
8989 61 If any provision of this Act, or the application thereof to any person or circumstance, is
9090 62held invalid, the remainder of the Act and the application of such provision to other persons or
9191 63circumstances shall not be affected thereby.